This page shows the latest PMBCL news and features for those working in and with pharma, biotech and healthcare.
Meanwhile, Gilead reported $216m in first-half sales from DLBCL and another NHL variant called primary mediastinal large B-cell lymphoma (PMBCL).
primary mediastinal B-cell lymphoma (PMBCL) and transformed follicular lymphoma (TFL).
Kite was the first to file its new therapy in Europe, seeking approval in August for DLBCL, transformed follicular lymphoma (TFL), and primary mediastinal B-cell lymphoma (PMBCL) in adults ineligible
Adult patients with DLBCL, PMBCL and TFL will be enrolled in the trial. ... Kite is currently enrolling adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma (PMBCL), and transformed follicular
cell lymphoma (PMBCL) who are ineligible for autologous stem cell transplant.
B-cell lymphoma (PMBCL) - on the strength of the trial results.
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...